Iron Chelators Dictate Immune Cells Inflammatory Ability: Potential Adjuvant Therapy for IBD
PMID: 28215151
Source: Curr Pharm Des
Publication date:
2017-02-21
Year:
2017
Abstract
Biomedical ‘big data’ has opened opportunities for data repurposing to reveal new insights into complex diseases. Public data on IBD have been repurposed for novel diagnostics and therapeutics, and these datasets continue to grow. Here, we discuss the practicalities and implications of open data informatics for IBD.